SCHEMBL5924

SCHEMBL5924

CCC[C@]1(O)CC[C@]2(CCN(c3ccc(C4CC4)cc3)C2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 9/20 0.38
ITGA2B P08514 9/20 0.38
DRD2 P14416 1/20 0.36
LIPE Q05469 1/20 0.35
ESR2 Q92731 1/20 0.35
CYP3A4 P08684 2/20 0.34
CYP2C19 P33261 2/20 0.34
HIF1A Q16665 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5474 0.85 ITGB3 (0.36) ITGB3ITGA2BDRD2LIPECYP3A4
SCHEMBL5843 0.84 ITGB3 (0.37) ITGB3ITGA2BCYP3A4CYP2C19HIF1A
SCHEMBL5381 0.84 CYP3A4 (0.39) ITGB3ITGA2BCYP3A4CYP2C19HIF1A
SCHEMBL5558 0.83 ESR2 (0.46) ITGB3ITGA2BESR2CYP3A4CYP2C19
SCHEMBL5651 0.81 LIPE (0.38) ITGB3ITGA2BLIPECYP3A4CYP2C19
SCHEMBL5406 0.79 KCNJ1 (0.39) ITGB3ITGA2BLIPECYP3A4CYP2C19
SCHEMBL5639 0.77 S1PR1 (0.41) LIPECYP3A4CYP2C19HIF1AMEN1
SCHEMBL5614 0.77 LIPE (0.60) LIPESLC6A4SLC6A3
SCHEMBL4962 0.76 RYR2 (0.41) ITGB3ITGA2BLIPECYP3A4CYP2C19
SCHEMBL1957562 0.74 CYP2D6 (0.54) CYP3A4CYP2C19HIF1AMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP claimed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO claimed